MobileMedMinder: A Networked Aide for Medication Compliance

MobileMedMinder：药物合规性的网络助手

• 批准号: 8550721
• 负责人: HUIPING LI
• 金额: $ 11.61万
• 依托单位: LIMAGING, LLC
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-09-30 至 2013-09-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8550721
• 关键词: Academic Medical Centers; Award; Car Phone; Caregivers; Chronic Disease; Client; Collaborations; Communication; Computer software; Contracts; Development; Devices; Diabetes Mellitus; Disease Management; Electronics; Enrollment; Goals; Hypertension; Intake; Internet; Link; Measures; Mental Depression; Methodology; Methods; Monitor; Ohio; Patients; Pharmaceutical Preparations; Phase; Physicians; Randomized Controlled Trials; Recommendation; Services; Small Business Innovation Research Grant; Social Network; Solutions; Study Subject; System; Testing; Time; Wireless Technology; base; behavior change; compliance behavior; medication compliance; prototype; trial comparing; usability; voice recognition

Under Phase I of the project (SBIR PHS 2008-1, "Development of Methodology for Measuring and Enhancing Compliance for Medications, Topic 33), the MobileMedMinder was successfully demonstrated. Phase II will involve collaboration to develop and commercialize the MobileMedMinder. This product will allow users to enroll and verify medication intake using the existing mobile devices, and link seemlessly to the web through a wireless connection. MobileMedMinder will provide the following: 1) automatic or semi-automatic entry of medication information through Medscanning, electronic pick lists, voice recognition. 2) Real-time communication with an on-line server where medication can be monitored and recommendations made from automated systems, caregivers or physicians directly or through social networking solutions. 3) If successful, MobileMedMinder can be extended as a mobile platform for chronic disease management system, such as diabetes, depression, hypertension, etc. A user-centered usability testing and subject study at the Ohio State University Medical Center is planned to provide a comprehensive, non-intrusive, portable solution in support of medication compliance. The ultimate goal is to develop a product for use by patients on a mobile/web platform to promote medication compliance and behavior change that can be subsequently commercialized.

在该项目的第一阶段（SBIR PHS 2008-1，“开发测量和提高药物依从性的方法，主题33），MobileMedMinder已成功演示。第二阶段将涉及合作开发和商业化MobileMedMinder。该产品将允许用户使用现有的移动设备登记和验证药物摄入，并通过无线连接无缝连接到网络。